Baidu
map

「导师梦工场」走进韩国首尔~关注生物医药的下一个大事件

2016-03-21 MedSci MedSci原创

3月16日-18日,2016第九届再生医学和干细胞韩国分会在首尔花园酒店举行。开幕式由美国路易斯维尔大学Mariusz Z. Ratajczak博士主持。美国Juventas Therapeutics公司的董事长兼执行总裁Rahul Aras博士,法国ICM脑和脊椎机构、生物技术和生物治疗实验室主任Philippe Ravassard博士,中国南京市第一医院泌尿外科主任贾瑞鹏教授等来宾出席了开幕式

3月16日-18日,2016第九届再生医学和干细胞韩国分会在首尔花园酒店举行。开幕式由美国路易斯维尔大学Mariusz Z. Ratajczak博士主持。美国Juventas Therapeutics公司的董事长兼执行总裁Rahul Aras博士,法国ICM脑和脊椎机构、生物技术和生物治疗实验室主任Philippe Ravassard博士,中国南京市第一医院泌尿外科主任贾瑞鹏教授等来宾出席了开幕式和主题演讲。梅斯医学(MedSci)作为国际媒体合作单位参加了本次大会。



“MedSci导师梦工场”走进韩国首尔会场


本次大会的主题是:生物医药的下一个大事件。再生医学的发展引起了世界各国的高度关注,成为国际生物学和医学领域的热门话题。而干细胞作为再生医学领域的一个重要主题,在研究与应用领域存在着巨大的潜力。目前,许多国家的政府、研究机构和企业都增加对这一产业投资并取得了惊人的成绩。第九届再生医学与干细胞大会即将在韩国首尔召开,本次会议主题涵盖再生医学和干细胞领域的热门话题,包括全球干细胞研究概况、干细胞技术、成体干细胞、干细胞治疗的新兴领域、组织工程与移植、干细胞在高通量筛选和药物发现 中的利用、干细胞和主要血管系统等七个方向的议题。此外,还有来自于全球50余位有影响力的人物和全球知名公司的代表在这次会议发表精彩演讲。


南京市第一医院泌尿外科贾瑞鹏主任医师在演讲



嘉宾精彩演讲

梅斯医学 (MedSci)作为本次大会的国际媒体合作单位,积极推动国际合作交流,为中国临床医学研究搭建国际合作平台。MedSci致力于改善医疗质量,为广大医生及科研人员提供及时的资讯报道和临床研究支持,以学术驱动临床,帮助医生成长,推动医疗质量的改善。

在移动医疗快速发展的大背景下,为帮助医生打造个人学术品牌,梅斯医学(MedSci)斥资8亿元推出“导师梦工场”计划,免费为1111名中国医生提供个性化品牌宣称和专业科研学术支持,协助中国医生打造个人学术品牌。目前火动正在火热报名中,结果将由网络投票产生,获奖医生每人将获得高达62-113万 人民币的学术支持,副高及以上医师报名可直接获得2000元录课奖励。

纽约大学阿布扎比分校教授 Kourosh Salehi Ashtiani与“导师梦工场”合影



你还在为自己的学术梦想苦苦追逐吗?你还在为找不到好的宣传平台而烦恼不堪吗?你还在为成为一个知名医生进退无门吗?来报名参加“导师梦工场”吧。在这里,你的学术,你做主!在这里,成就你的导师梦想!在这里,打造你的学术品牌!


特邀导师

你还在等什么?点击识别二维码报名吧~



祝大家一周愉快!❤️


现在报名“导师梦工场”,抢1111份梦想合同,价值62-113万/人,含360度学术支持服务和量身定制的个人学术品牌打造。副主任及以上报名立领2000元录课金!快点识别二维码报名吧~

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1334798, encodeId=ec791334e9884, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Tue Mar 22 23:50:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408736, encodeId=8b381408e3651, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Tue Mar 22 23:50:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543045, encodeId=73391543045af, content=<a href='/topic/show?id=336a46e0263' target=_blank style='color:#2F92EE;'>#导师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46702, encryptionId=336a46e0263, topicName=导师)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730f13527667, createdName=124987a0m70(暂无昵称), createdTime=Tue Mar 22 23:50:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72441, encodeId=f8abe244107, content=好文章啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Mar 21 21:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1334798, encodeId=ec791334e9884, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Tue Mar 22 23:50:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408736, encodeId=8b381408e3651, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Tue Mar 22 23:50:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543045, encodeId=73391543045af, content=<a href='/topic/show?id=336a46e0263' target=_blank style='color:#2F92EE;'>#导师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46702, encryptionId=336a46e0263, topicName=导师)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730f13527667, createdName=124987a0m70(暂无昵称), createdTime=Tue Mar 22 23:50:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72441, encodeId=f8abe244107, content=好文章啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Mar 21 21:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=)]
    2016-03-22 cathymary
  3. [GetPortalCommentsPageByObjectIdResponse(id=1334798, encodeId=ec791334e9884, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Tue Mar 22 23:50:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408736, encodeId=8b381408e3651, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Tue Mar 22 23:50:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543045, encodeId=73391543045af, content=<a href='/topic/show?id=336a46e0263' target=_blank style='color:#2F92EE;'>#导师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46702, encryptionId=336a46e0263, topicName=导师)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730f13527667, createdName=124987a0m70(暂无昵称), createdTime=Tue Mar 22 23:50:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72441, encodeId=f8abe244107, content=好文章啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Mar 21 21:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1334798, encodeId=ec791334e9884, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Tue Mar 22 23:50:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408736, encodeId=8b381408e3651, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Tue Mar 22 23:50:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543045, encodeId=73391543045af, content=<a href='/topic/show?id=336a46e0263' target=_blank style='color:#2F92EE;'>#导师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46702, encryptionId=336a46e0263, topicName=导师)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730f13527667, createdName=124987a0m70(暂无昵称), createdTime=Tue Mar 22 23:50:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72441, encodeId=f8abe244107, content=好文章啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Mar 21 21:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=)]
    2016-03-21 milkshark

    好文章啊

    0

相关资讯

2016深圳神经病理读片会邀请函

邀请函   尊敬的各位病理科及临床同道:诚邀您参加广东省抗癌协会神经肿瘤专业委员会神经病理学组2016年第一季度神经病理读片会暨中山大学肿瘤医院——深圳市第二人民医院联合检测中心授牌仪式!本次会议特邀省内权威病理专家进行肿瘤分子病理专题学术讲座,内容丰富。再次诚邀您能拨冗出席! 会议时间:2016年3月12日全天  09:00——18:00 会议地点:深

中国微循环学会宜宾会议日程安排

中国微循环学会是从事微循环领域相关研究和学术交流的国家一级学会。英文名称Chinese Society of Microcirculation,简称:CSM。本会是我国从事微循环研究的生命科学、医学以及相关学科的科技人员与医学工作者自愿组成的、依法登记的公益性、学术性、非营利性社会团体,是联系微循环领域科技人员与医学工作者的平台和纽带,是一支推动我国微循环领域科学技术和医疗卫生事业发展的重要社会力

Baidu
map
Baidu
map
Baidu
map